MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Nephros ROA Ratio 2011-2026 | NEPH
Annual ROA Ratio Nephros
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.75 | 0.66 | -13.28 | -64.61 | -21.91 | -25.75 | -29.41 | -32.22 | -16.24 | -113.22 | -77.78 | -218.79 | -128.0 | -92.46 | -59.09 | 244.03 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 244.03 | -218.79 | -39.96 |
Quarterly ROA Ratio Nephros
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.23 | 10.98 | 5.83 | 2.42 | -2.32 | -3.99 | -9.92 | -10.12 | -8.64 | -36.46 | -42.4 | -50.9 | -48.1 | -54.95 | -33.39 | -28.78 | -16.11 | -21.58 | -23.67 | -23.35 | -20.35 | -26.75 | -29.38 | -32.03 | -26.1 | -31.46 | -31.52 | -36.96 | -25.36 | -38.04 | -48.45 | -55.64 | -42.1 | -68.47 | -86.96 | -102.41 | -88.76 | -103.4 | -122.75 | -85.45 | -54.23 | 26.59 | -117.25 | -175.74 | -181.86 | -265.21 | -390.31 | -179.43 | -75.22 | -99.39 | -37.42 | -8.93 | -61.34 | -71.68 | -62.57 | -58.9 | -43.11 | -10.34 | -15.07 | -17.7 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 26.59 | -390.31 | -56.44 |
ROA Ratio of other stocks in the Medical instruments industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
3.02 | $ 59.61 | -1.28 % | $ 11.9 B |  USA |
 |
Atrion Corporation
ATRI
|
7442.15 | - | - | $ 810 M | USA |
 |
iRhythm Technologies
IRTC
|
-4.37 | $ 114.0 | -0.14 % | $ 3.65 B | USA |
 |
Luminex Corporation
LMNX
|
1.84 | - | - | $ 1.75 B | USA |
 |
ICU Medical
ICUI
|
0.02 | $ 118.72 | -3.47 % | $ 2.93 B | USA |
 |
Repro Med Systems
KRMD
|
-9.35 | $ 3.9 | -2.01 % | $ 180 M | USA |
 |
Akers Biosciences, Inc.
AKER
|
-161.51 | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
13.96 | $ 421.12 | -1.62 % | $ 150 B | USA |
 |
LeMaitre Vascular
LMAT
|
9.37 | $ 97.31 | -2.2 % | $ 2.2 B | USA |
 |
Alcon
ALC
|
1.34 | $ 63.64 | -0.56 % | $ 40.4 B |  Schweiz |
 |
Masimo Corporation
MASI
|
-11.61 | $ 178.47 | 0.07 % | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
26.44 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
0.66 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
-12.76 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
4.77 | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-58.15 | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
0.83 | $ 23.22 | -2.68 % | $ 3.9 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
7.12 | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
-74.82 | $ 6.27 | -2.49 % | $ 53.2 K | USA |
 |
Haemonetics Corporation
HAE
|
6.84 | $ 56.29 | -1.4 % | $ 2.83 B | USA |
 |
STAAR Surgical Company
STAA
|
-17.81 | $ 32.07 | 0.19 % | $ 1.59 B | USA |
 |
STERIS plc
STE
|
6.06 | $ 212.11 | -1.79 % | $ 20.9 B | USA |
 |
Teleflex Incorporated
TFX
|
-13.04 | $ 129.71 | -0.44 % | $ 5.79 B | USA |
 |
Isoray
ISR
|
-38.63 | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
-14.32 | $ 144.01 | 1.31 % | $ 6.97 B | USA |
 |
InfuSystem Holdings
INFU
|
6.59 | $ 8.77 | 1.86 % | $ 181 M | USA |
 |
Microbot Medical
MBOT
|
-16.12 | $ 1.85 | - | $ 84.7 M |  Israel |
 |
Milestone Scientific
MLSS
|
-73.3 | $ 0.33 | -2.62 % | $ 27.1 M | USA |
 |
Merit Medical Systems
MMSI
|
4.78 | $ 61.36 | -1.92 % | $ 3.63 B | USA |
 |
Utah Medical Products
UTMD
|
2.09 | $ 63.34 | -0.57 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
11.56 | $ 302.89 | 0.9 % | $ 21.9 B | USA |
 |
Pulse Biosciences
PLSE
|
-76.99 | $ 24.55 | -9.41 % | $ 1.65 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-11.01 | $ 10.07 | -3.27 % | $ 2.01 B | USA |
 |
Retractable Technologies
RVP
|
-8.81 | $ 0.64 | -7.25 % | $ 19.2 M | USA |
 |
Pro-Dex
PDEX
|
14.67 | $ 59.27 | 1.06 % | $ 195 M | USA |
 |
Predictive Oncology
POAI
|
-440.73 | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
-1.13 | $ 20.76 | -1.42 % | $ 991 M | USA |
 |
Stereotaxis
STXS
|
-41.42 | $ 1.85 | -4.64 % | $ 168 M | USA |
 |
Baxter International
BAX
|
-4.77 | $ 17.3 | -2.7 % | $ 8.87 B | USA |
 |
ResMed
RMD
|
15.3 | $ 201.88 | -0.29 % | $ 29.5 B | USA |
 |
AtriCure
ATRC
|
-1.75 | $ 28.12 | -0.11 % | $ 1.34 B | USA |
 |
Harvard Bioscience
HBIO
|
-70.81 | $ 5.25 | -4.89 % | $ 233 M | USA |
 |
NeuroMetrix
NURO
|
-50.94 | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
-12.13 | $ 10.77 | -2.36 % | $ 440 M | USA |
 |
Becton, Dickinson and Company
BDX
|
3.03 | $ 143.47 | -0.69 % | $ 41.3 B | USA |
 |
OraSure Technologies
OSUR
|
-17.05 | $ 3.0 | 1.69 % | $ 220 M | USA |
 |
Repligen Corporation
RGEN
|
1.66 | $ 102.87 | -0.49 % | $ 5.78 M | USA |